arznei-telegramm Logo a-t Kurzlogo
    ❮ a-t 6/2013 a-t ❯
    This is a translation of the table of contents. One article of each issue is translated and freely available.
    table of contents
    NEW ON THE MARKET

    Rifaximin (XIFAXAN) for the prevention of hepatic encephalopathy

    TREATMENT RECOMMENDATION

    Switching of levothyroxine preparations

    a-t READERS' QUESTIONS AND COMMENTS

    Mistletoe for cancer: What is the current state of scientific knowledge?

    Rebates according to the Pharmaceutical Market Restructuring Act in Germany (AMNOG) in relation to comparative treatment and added benefit

    Switching to generics in antiepileptic treatment

    IN BRIEF

    Sanofi - fines for disinformation campaign against clopidogrel generics
    free

    Physical therapy first option for knee osteoarthritis with meniscal tear

    TEBONIN 120 mg BEI OHRGERÄUSCHEN [Ginkgo biloba for tinnitus]

    FUMADERM, progressive multifocal leukoencephalopathy and the Federal Institute for Drugs and Medical Devices (BfArM)

    Counterfeit medicines - a growing problem

    CURRENT ADR NETWORK REPORT

    Lichenoid reactions on beta-receptor blockers

    SIDE EFFECTS

    Minocycline (SKID u.a.): market withdrawal overdue

    arznei-telegramm

    Independent drug information – in English

    Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

    Browse free articles